Annual EBIT
-$15.32 M
-$10.01 M-188.86%
December 31, 2023
Summary
- As of February 7, 2025, CTCX annual earnings before interest & taxes is -$15.32 million, with the most recent change of -$10.01 million (-188.86%) on December 31, 2023.
- During the last 3 years, CTCX annual EBIT has fallen by -$11.34 million (-284.84%).
- CTCX annual EBIT is now -284.84% below its all-time high of -$3.98 million, reached on December 31, 2021.
Performance
CTCX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.87 M
+$423.80 K+12.86%
September 30, 2024
Summary
- As of February 7, 2025, CTCX quarterly earnings before interest & taxes is -$2.87 million, with the most recent change of +$423.80 thousand (+12.86%) on September 30, 2024.
- Over the past year, CTCX quarterly EBIT has increased by +$5.86 million (+67.11%).
- CTCX quarterly EBIT is now -22709.45% below its all-time high of $12.70 thousand, reached on December 31, 2023.
Performance
CTCX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$9.68 M
+$5.86 M+37.70%
September 30, 2024
Summary
- As of February 7, 2025, CTCX TTM earnings before interest & taxes is -$9.68 million, with the most recent change of +$5.86 million (+37.70%) on September 30, 2024.
- Over the past year, CTCX TTM EBIT has increased by +$8.43 million (+46.56%).
- CTCX TTM EBIT is now -3286.50% below its all-time high of -$285.90 thousand, reached on June 30, 2022.
Performance
CTCX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CTCX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -188.9% | +67.1% | +46.6% |
| 3 y3 years | -284.8% | -3.0% | -26.6% |
| 5 y5 years | -284.8% | -3.0% | -26.6% |
CTCX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
| 5 y | 5-year | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
| alltime | all time | -284.8% | at low | <-9999.0% | +67.1% | -3286.5% | +46.6% |
Carmell Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.87 M(-12.9%) | -$9.68 M(-37.7%) |
| Jun 2024 | - | -$3.30 M(-6.6%) | -$15.54 M(-10.1%) |
| Mar 2024 | - | -$3.53 M(<-9900.0%) | -$17.28 M(+12.8%) |
| Dec 2023 | -$15.32 M | $12.70 K(-100.1%) | -$15.32 M(-15.5%) |
| Sep 2023 | - | -$8.73 M(+73.5%) | -$18.12 M(+29.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$5.03 M(+221.5%) | -$13.96 M(+51.5%) |
| Mar 2023 | - | -$1.57 M(-43.9%) | -$9.21 M(+20.5%) |
| Dec 2022 | -$5.30 M(+33.2%) | -$2.79 M(-39.1%) | -$7.65 M(+57.4%) |
| Sep 2022 | - | -$4.57 M(+1500.2%) | -$4.86 M(+1600.2%) |
| Jun 2022 | - | -$285.90 K | -$285.90 K |
| Dec 2021 | -$3.98 M | - | - |
FAQ
- What is Carmell Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Carmell Therapeutics?
- What is Carmell Therapeutics annual EBIT year-on-year change?
- What is Carmell Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly EBIT year-on-year change?
- What is Carmell Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Carmell Therapeutics?
- What is Carmell Therapeutics TTM EBIT year-on-year change?
What is Carmell Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CTCX is -$15.32 M
What is the all time high annual EBIT for Carmell Therapeutics?
Carmell Therapeutics all-time high annual earnings before interest & taxes is -$3.98 M
What is Carmell Therapeutics annual EBIT year-on-year change?
Over the past year, CTCX annual earnings before interest & taxes has changed by -$10.01 M (-188.86%)
What is Carmell Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CTCX is -$2.87 M
What is the all time high quarterly EBIT for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly earnings before interest & taxes is $12.70 K
What is Carmell Therapeutics quarterly EBIT year-on-year change?
Over the past year, CTCX quarterly earnings before interest & taxes has changed by +$5.86 M (+67.11%)
What is Carmell Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CTCX is -$9.68 M
What is the all time high TTM EBIT for Carmell Therapeutics?
Carmell Therapeutics all-time high TTM earnings before interest & taxes is -$285.90 K
What is Carmell Therapeutics TTM EBIT year-on-year change?
Over the past year, CTCX TTM earnings before interest & taxes has changed by +$8.43 M (+46.56%)